Jupiter Topco LLC Takes Position in Waystar Holding Corp. $WAY

Jupiter Topco LLC bought a new position in Waystar Holding Corp. (NASDAQ:WAY) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 2,871,893 shares of the company’s stock, valued at approximately $58,960,000. Jupiter Topco LLC owned about 1.50% of Waystar at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Clarkston Capital Partners LLC purchased a new position in shares of Waystar during the first quarter valued at approximately $22,917,000. Hsbc Holdings PLC purchased a new stake in shares of Waystar in the first quarter worth approximately $5,625,000. Dimensional Fund Advisors LP lifted its stake in shares of Waystar by 73.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,046,396 shares of the company’s stock worth $49,329,000 after acquiring an additional 868,853 shares during the last quarter. Diamond Hill Capital Management LLC Investment Advisor bought a new stake in shares of Waystar during the 2nd quarter worth approximately $43,314,000. Finally, Perigon Wealth Management LLC bought a new stake in shares of Waystar during the 2nd quarter worth approximately $878,000.

Trending Headlines about Waystar

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Waystar unveiled new AltitudeAI agentic capabilities designed to autonomously manage claims, denials, documentation and patient-billing workflows. The tools are intended to improve healthcare providers’ revenue-cycle efficiency and strengthen Waystar’s long-term growth opportunity. Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
• Positive Sentiment: Royal Bank of Canada reaffirmed its Outperform rating and set a $44 price target, implying substantial potential upside from the referenced share price. Needham also maintained a Buy rating with a $33 target, reinforcing positive sell-side sentiment. Analyst Rating Updates
• Positive Sentiment: Management reaffirmed its long-term financial guidance during investor day, signaling that the company continues to expect its growth strategy—including AI-driven revenue-cycle automation—to remain on track. Waystar Analyst/Investor Day Slideshow
• Neutral Sentiment: Coverage of the product launch highlighted Waystar’s expansion of agentic AI across claims, denials and documentation. The rollout supports the company’s strategic positioning, but the financial impact and adoption pace have yet to be quantified. Waystar Expands AI-Powered Agentic Revenue Cycle Tools
• Negative Sentiment: RBC said the investor-day update lacked new KPIs, which disappointed investors seeking clearer evidence of execution, customer adoption and the measurable impact of the AI strategy. Waystar Reaffirms Long-Term Guidance, Lack of KPIs Disappoints, RBC Says

Insider Transactions at Waystar

In other Waystar news, CEO Matthew J. Hawkins sold 60,038 shares of the stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $25.01, for a total transaction of $1,501,550.38. Following the transaction, the chief executive officer directly owned 1,835,081 shares in the company, valued at $45,895,375.81. This represents a 3.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 3.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $39.00 price objective on shares of Waystar in a research report on Friday, July 31st. BMO Capital Markets reissued an “outperform” rating on shares of Waystar in a research note on Thursday. Truist Financial lowered their target price on shares of Waystar from $38.00 to $33.00 and set a “buy” rating for the company in a research note on Thursday, August 13th. JPMorgan Chase & Co. cut their price target on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Finally, Wall Street Zen lowered shares of Waystar from a “buy” rating to a “hold” rating in a report on Sunday, May 24th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Waystar currently has an average rating of “Moderate Buy” and an average price target of $35.39.

Waystar Price Performance

Shares of WAY stock opened at $25.25 on Friday. Waystar Holding Corp. has a twelve month low of $17.26 and a twelve month high of $41.47. The stock has a market capitalization of $4.84 billion, a price-to-earnings ratio of 36.07, a P/E/G ratio of 0.94 and a beta of 0.06. The stock has a fifty day simple moving average of $22.71 and a two-hundred day simple moving average of $22.66. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36.

Waystar (NASDAQ:WAY) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. The firm had revenue of $319.67 million for the quarter, compared to analyst estimates of $316.21 million. Waystar had a return on equity of 7.03% and a net margin of 11.18%.The business’s revenue for the quarter was up 18.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.36 earnings per share. On average, analysts predict that Waystar Holding Corp. will post 1.47 EPS for the current fiscal year.

Waystar Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.